✦ LIBER ✦

824 Multi-parametric magnetic resonance imaging in the diagnosis and characterization of prostate cancer prior to first biopsy in men at risk: The PROMIS study

✍ Scribed by H.U. Ahmed; R. Gabe; R. Kaplan; C. Parker; M. Emberton

Book ID: 119624755
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 34 KB
Volume: 11
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(12)60821-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multi-Parametric Magnetic Resonance Imag

Multi-Parametric Magnetic Resonance Imaging to Rule-In and Rule-Out Clinically Important Prostate Cancer in Men at Risk: A Cohort Study

✍ Rouse, Paul; Shaw, Greg; Ahmed, Hashim U.; Freeman, Alex; Allen, Clare; Emberton 📂 Article 📅 2011 🏛 S. Karger AG 🌐 English ⚖ 532 KB

MP79-10 THE ROLE OF PROSTATE CANCER ANTI

MP79-10 THE ROLE OF PROSTATE CANCER ANTIGEN 3 TEST AND MULTI-PARAMETRIC PROSTATIC MAGNETIC RESONANCE IMAGING FOR DIAGNOSIS OF PROSTATE CANCER IN PATIENT WITH MULTIPLE PRIOR NEGATIVE BIOPSIES

✍ Alkasab, Thamir; Kulkarni, Girish; Zlotta, Alexander; Finelli, Antonio; Hamilton 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 41 KB

Can multiparametric magnetic resonance i

Can multiparametric magnetic resonance imaging predict upgrading of transrectal ultrasound biopsy results at more definitive histology?11Mohamed Abd-Alazeez receives funding from the Egyptian government. Mark Emberton and Hashim U. Ahmed receive funding from USHIFU and Advanced Medical Diagnostics for clinical trials. Mark Emberton is a paid consultant for Steba Biotech, USHIFU and Sanofi-Aventis. Mark Emberton has received research support by GSK for a study evaluating the role of MRI in men with prostate cancer. Mark Emberton and Hashim Ahmed have previously received medical consultancy fees from GE Healthcare/Oncura and Hashim Ahmed previously from Steba Biotech. Mark Emberton is a medical director of Mediwatch PLC. Hashim Uddin Ahmed and Mark Emberton receive funding from the Medical Research Council, the NIHR-HTA, NIHR-i4i, the US NIH/NCI, Pelican Cancer Foundation, Prostate Cancer UK, and St Peter׳s Trust. This work was part funded by research support for Mark Emberton and Alex Kirkham from the UK National Institute of Health Research UCLH/UCL Comprehensive Biomedical Research Centre, London, UK.

✍ Abd-Alazeez, Mohamed; Ahmed, Hashim U.; Arya, Manit; Allen, Clare; Dikaios, Niko 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 415 KB